Variation is seen in the prevalence and patterns of risk factors for dementia, but broadly similar clusters of risk factors are observed across countries and regions.

A class II FDA recall of generic prednisolone acetate ophthalmic suspension eye drops was issued due to the presence of a foreign substance.

Patients undergoing surgery for rhegmatogenous retinal detachment experience early quality of life improvements that plateau with time.

Ophthalmic ambulatory surgical centers face financial challenges under Medicare facility fee reimbursements for high-cost procedures.

The FDA granted Priority Review to the supplemental Biologics License Application for satralizumab for patients with thyroid eye disease.

Optometrists Anastasia Logotheti, OD, and Andrew Pucker, OD, discuss strategies for mitigating the impact of topical glaucoma medications on ocular surface health. A 78-year-old woman with advanced ...

Three in 10 young adults do not have a primary care doctor, according to the results of a survey released June 29 by The Ohio State University Wexner Medical Ce ...

The US Food and Drug Administration has granted accelerated approval to Tzield (teplizumab-mzwv) to delay the decline in endogenous insulin production in children aged 8 to 17 years recently diagnosed ...

The AAO recognizes visual electrophysiology as a useful adjunct in select glaucoma cases when structural and functional tests do not match.

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) exposures reported to U.S. poison centers increased following 2021 U.S. Food and Drug Administration (FDA) approval for weight loss.

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is common people with eating disorders. HealthDay News — Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is common people with eating ...